An Overview of Nanotechnologies for Drug Delivery to the Brain

• Published in: Pharmaceutics Vol. 14; no. 2; p. 224
• Main Authors: Ayub, Ahsan, Wettig, Shawn
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 19-01-2022; MDPI
• Subjects: Biochemistry; brain; Brain research; brain tumours; cancer; Chemistry; drug delivery; Drug interactions; Molecular weight; nanomedicine; nanoparticle; Nanotechnology; Proteins; R&D; Research & development; Review; polymer; micelle; targeting; dendrimer; nanomedicine; nanoparticle; cancer; drug delivery; brain; brain tumours
• ISSN: 1999-4923; 1999-4923
• DOI: 10.3390/pharmaceutics14020224

Drug delivery to the brain has been one of the toughest challenges researchers have faced to develop effective treatments for brain diseases. Owing to the blood-brain barrier (BBB), only a small portion of administered drug can reach the brain. A consequence of that is the need to administer a higher dose of the drug, which, expectedly, leads to a variety of unwanted side effects. Research in a variety of different fields has been underway for the past couple of decades to address this very serious and frequently lethal problem. One area of research that has produced optimistic results in recent years is nanomedicine. Nanomedicine is the science birthed by fusing the fields of nanotechnology, chemistry and medicine into one. Many different types of nanomedicine-based drug-delivery systems are currently being studied for the sole purpose of improved drug delivery to the brain. This review puts together and briefly summarizes some of the major breakthroughs in this crusade. Inorganic nanoparticle-based drug-delivery systems, such as gold nanoparticles and magnetic nanoparticles, are discussed, as well as some organic nanoparticulate systems. Amongst the organic drug-delivery nanosystems, polymeric micelles and dendrimers are discussed briefly and solid polymeric nanoparticles are explored in detail.